About Teleflex, Inc. 
Teleflex, Inc.
Pharmaceuticals & Biotechnology
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.
Company Coordinates 
Company Details
550 E Swedesford Rd Ste 400 , WAYNE PA : 19087-1601
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 129 Schemes (80.62%)
Foreign Institutions
Held by 274 Foreign Institutions (20.79%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Liam Kelly
Chairman of the Board, President, Chief Executive Officer
Mr. George Babich
Lead Independent Director
Ms. Candace Duncan
Independent Director
Ms. Gretchen Haggerty
Independent Director
Mr. John Heinmiller
Independent Director
Dr. Stephen Klasko
Independent Director
Revenue and Profits:
Net Sales:
781 Million
(Quarterly Results - Jun 2025)
Net Profit:
123 Million
Pharmaceuticals & Biotechnology
USD 5,892 Million (Small Cap)
13.00
NA
1.08%
0.38
11.18%
1.39






